CD79A and COVID-19: In patients with COVID-19, early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralization was more closely correlated with IgA than IgM or IgG98 and we report higher proportions of IgA plasma cells in the airways of patients with COVID-19.